Compared with the female craniopharyngioma patients (18 cases), the level of survivin expression was significantly higher in the overall male craniopharyngioma patient population (32 cases) (P=0.002) and in those males with the adamantinomatous tumor type (P<0.001). The gene discussed is BIRC5; the disease is craniopharyngioma.